What they were paid
NOVAVAX Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $81,371 | $121,021 | $162,070 | $0 | $364,462 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NOVAVAX INC DEF 14A filed April 27, 2026, accession 0001628280-26-027328, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025NOVAVAX pays directors a $55,000 cash retainer and $350,000 in Options and RSUs.
Committees
FY2025 · as the proxy prints themAudit
The rest of the NOVAVAX board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Charles W. Newton | Independent Director | $491,949 |
| David Mott | Chair of the Board | $365,591 |
| Gregg H. Alton, J.D | Independent Director | $355,091 |
| John C. Jacobs | Director | $0 |
| John W. Shiver, Ph.D | Independent Director | $516,545 |
| Margaret G. McGlynn, R. Ph | Independent Director | $402,278 |
| Rachel K. King | Independent Director | $353,091 |
| Richard J. Rodgers | Independent Director | $375,449 |
The full NOVAVAX compensation record
free company briefThis page is one director within NOVAVAX's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat